Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform
Coave Therapeutics (pronounced ‘cove’; formerly Horama), a clinical stage biotechnology company focused on developing life […]
Cityzenith and SafelyThrive Digital Twin Tech Partnership Delivers Major Solution to 'COVID Delta' Variant
As the world reels from the threat of COVID-19’s new and highly contagious Delta variant, […]
Panakès Partners Announces the First Closing of its New 'Purple' Global Biotech/Medtech Fund at €150 Million ($180 Million)
Panakès Partners, the leading Italian venture capital firm in the Life Sciences sector, announces the […]
NHS England Announces New Innovative Medicines Fund to Fast-track Promising New Drugs
NHS patients are set to benefit from early access to potentially life-saving new medicines, including cutting-edge gene therapies, […]
RemedyBio Completes €10.5M Financing from European Innovation Council
RemedyBio, an immunology focused discovery and development company, today announces the final closing of an […]
AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round
Lunit, a leading AI startup in AI-powered cancer solutions, today announced a strategic investment of […]
Pfizer Announces New Investor Relations Leader
Pfizer Inc. (NYSE: PFE) today announced that Christopher Stevo has joined the company as Senior […]
Calyxt Appoints Michael A. Carr as Chief Executive Officer
Calyxt, Inc. (NASDAQ: CLXT), a plant-based biotechnology platform company, today announced the appointment of Michael A. Carr as President […]
PEP-Therapy Extends Series-A Financing, Raising a Total of €5.4 Million to Progress the Clinical Development of its Lead Candidate PEP-010
PEP-Therapy, a biotechnology company developing cell penetrating peptides as targeted therapies for the treatment of […]
Heru Bolsters Executive Team with Seasoned Industry Veterans
Heru Inc., the developer of wearable AI-powered vision diagnostics and augmentation software, has expanded its […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more